Objective: Breast hamartomas are benign breast tumors, which are observed very rarely. We aimed to share our surgical approaches and a comparison of preoperative and postoperative pathology results of patients applying to breast polyclinics.
Introduction
Breast hamartomas are rarely seen, slowly growing and benign tumors (1) (2) (3) (4) . They can be observed in all age groups after puberty. Hamartomas in the male breast have been reported in only three cases. These tumors have smooth contours, and may include fat, fibrous and glandular tissue in various amounts. More than 60% of these are soft and cannot be palpated (5) . As their contents vary, mammography findings show differences. A diagnosis is established by considering physical examination, imaging, and histopathology together (6) .
Although these lesions were first called mastoma by Prym in 1928, then adenolipoma by Splading in 1945, and by Hogeman and Ostberg post-lactational breast tumors in 1968, they were finally identified as hamartoma by Arrigoni (1) in 1971.
In this study, we clinically, radiologically and histopathologically evaluated hamartoma which we have detected in our clinic.
Materials and Methods

Out of 32.000 patients applying to the Breast Polyclinic of Haseki Training and Research Hospital between dates of March 2007 and
October 2012, 12 patients with the diagnosis of breast hamartoma were examined retrospectively. The diagnosis of hamartoma was established by considering physical examination, imaging methods and histopathological findings together. Patients who had been diagnosed underwent a mass excision surgery. Excised masses were histopathologically reexamined once again. Patients who had been diagnosed by a biopsy performed prior to surgery, but were identified as nonhamartoma neoplasm in the pathological examination following the surgery, were excluded. Patients were asked to visit for purposes of control examination at 6-month intervals. Median follow-up period was 31 (min-max; 3-54) months. There was no ethics committee approval for this study. Written informed consent was obtained from patients who participated in this study.
Statistical analysis
Data concerning demographicand clinical characteristics were analyzed by using descriptive methods (means, minimum-maximum). The statistical software used was SPSS for Windows, version 15.0 (SPSS Inc., Chicago, IL, USA).
Results
All our patients applied to our polyclinic with the complaint of a palpable mass in the breast. All our patients were female, and the average age was 35 (min-max; 17-58). Hamartomas were detected in four patients in the right breast, and in seven patients in their left. The average diameter of the lesions was 7.3 cm (min-max; [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . The diameter of the lesion was above 10 cm in three patients, and those were evaluated as giant hamartoma ( Table 1) .
Our patients who had been identified with a palpable mass in the physical examination underwent ultrasonography and/or mammography. All our patients were identified as having a solid lesion. Results related to imaging had a benign appearance in ten patients, and two patients were suspected of malignancy. Two patients with suspected malignancy underwent further imaging procedures by Magnetic Resonance Imaging (MRI); however, no findings which led to a differential diagnosis were detected radiologically, and the lesion identified in both cases was primarily considered as a fibroadenolipoma.
All patients underwent a preoperative biopsy. One patient received a fine needle aspiration biopsy (FNAB), while 11 patients underwent a core biopsy. Preoperative histopathological findings were consistent with hamartoma in eleven patients. In one patient receiving core biopsy, histopathological findings were found to be compatible with a phyllodes tumor. However, all the specimens were found to be consistent with hamartoma in the pathological examination of postoperatively excised masses.
Discussion and Conclusions
Breast hamartoma make up 0.7% of benign breast tumors in females (7) . The average age of incidence is around 45 years, and most of the patients are above 35 years of age. In our series, the patients were aged between 17-58, and the average age was determined as 35 years. Six patients were above 35 years of age, and six patients were under 35. Three cases of breast hamartoma have been reported in the literature, which could also be seen in males (8) (9) (10) . All patients in our series were female.
The size of hamartomas in the literature vary between 1-25 cm (2) . In our series, lesions with varying sizes of 3-21 cm were detected, and the average diameter was determined as 7.3 cm. Hamartomas are painless and slowly-growing tumors, which are mostly localized in the outer quadrant of the breast (7, 11) . All the patients in our study presented with the complaint of a palpable painless mass. In studies, it has been reported that hamartomas are recorded as 2 times more frequently in the left breast and that 39% of those are localized in the upper outer quadrant (12) . In our series, it has also been identified that lesions are localized twice as often in the left breast (in the left breast in eight patients, in the right breast in four patients). Four cases were identified with hamartoma in the upper outer quadrant, six cases in the lower outer quadrant, and two cases had those in the lower inner quadrant ( Table 2) .
They are painless, slowly-growing masses, which are mostly localized in the outer quadrant and do not invade the surrounding tissues. These lesions, which may be taken for fibroadenoma or phyllodes tumors, cannot be palpated and are only identified in mammography.
Pathologically, there are findings where a microglandular adenosis is present in fibroadipose stroma surrounded by a thin fibrous capsule (13) . In these lesions, a cure can be ensured by local excision (14) . They are not malignant lesions, but cases with recurrence have been reported (3, 4) . The median follow-up period of the patients in our series was 31 months (min-max; 3-54), and no recurrence was noted. Very rarely, it has also been reported that hamartomas develop into carcinoma (7) . While an invasive lobular carcinoma is reported to develop in some publications, development of ductal carcinoma is the most frequently reported (15) (16) (17) (18) (19) (20) (21) . Thus, once the diagnosis is established, an excision should be performed (Figure 1-3) .
Hamartomas are soft, mobile lesions with smooth contours, which have a nature similar to normal breast tissue (3) . They are lesions that can be well-contoured and have thin capsules, and which show opacity in various degrees mammographically, depending on the fat amount in the breast tissue ( Figure 4 ). Ultrasonography findings resemble the mammographic appearance. Breast hamartomas are not a substitute for the breast tissue, but they only occupy space by pushing the breast parenchyma (4, 22) . In MRI, they appear as well-contoured and intense with breast tissue, surrounded with smooth capsule. All our patients underwent ultrasonography. Further imaging was performed on six patients by mammography and on two patients by MRI. Erdem et al. (23) reported that clinical and imaging findings are more important in diagnosis, and that the fine needle aspiration biopsy or the core biopsy has a limited contribution in diagnosis. However, in our study no findings suggesting hamartomas were detected in patients by imaging methods. Out of twelve patients, 11 of those were diagnosed with hamartoma by a preoperative biopsy.
In this study, we determined that preoperative biopsies show a substantial correlation with postoperative pathology results. Therefore, also considering the risk of a developing carcinoma, though very rarely, local excision by a preoperative biopsy should be performed on patients diagnosed with breast hamartoma. 
